chimpanzee PATR-DQB1 antibody | antibody review based on formal publications

This is a Validated Antibody Database (VAD) review about chimpanzee PATR-DQB1, based on 101 published articles (read how Labome selects the articles), using PATR-DQB1 antibody in all methods. It is aimed to help Labome visitors find the most suited PATR-DQB1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.

PATR-DQB1 synonym: Patr-DRB1; mhc-DRB

BioLegend

mouse monoclonal (L243) 307667 307666 307665 307661 307669 307668 307677 307675 307676 307678 307618 307617 307602 307626 307625 307620 307621 307622 307619 307673 307648 307651 307674 307659 307663 307656 307671 307672 307681 307680 307679 307683	flow cytometry; human; 1:300; loading ...; fig 6b	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples at 1:300 (fig 6b). Nat Commun (2021) ncbi
mouse monoclonal (L243) 307667 307666 307665 307661 307669 307668 307677 307675 307676 307678 307638 307602 307626 307625 307620 307621 307622 307619 307673 307637 307648 307651 307674 307659 307663 307656 307671 307672 307681 307680 307679 307683	flow cytometry; human; loading ...; fig 3b	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 3b). Acta Neuropathol (2021) ncbi
mouse monoclonal (L243) 307667 307666 307665 307661 307669 307640 307668 307677 307675 307676 307639 307678 307602 307626 307625 307620 307621 307622 307619 307673 307648 307651 307674 307659 307663 307656 307671 307672 307681 307680 307679	flow cytometry; human; loading ...; fig 3a	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 3a). elife (2020) ncbi
mouse monoclonal (L243) 307610	flow cytometry; human; loading ...; fig s3c	BioLegend PATR-DQB1 antibody (BioLegend, 307610) was used in flow cytometry on human samples (fig s3c). Cell (2021) ncbi
mouse monoclonal (L243) 307667 307666 307665 307661 307669 307668 307602 307626 307625 307620 307621 307622 307619 307648 307651 307659 307663 307656 307671 307672	flow cytometry; human; loading ...; fig 1b	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 1b). J Immunother Cancer (2020) ncbi
mouse monoclonal (L243) 307638	flow cytometry; human; loading ...; fig 2e	BioLegend PATR-DQB1 antibody (BioLegend, 307638) was used in flow cytometry on human samples (fig 2e). Cell (2020) ncbi
mouse monoclonal (L243) 307667 307666 307665 307661 307669 307668 307618 307617 307602 307626 307625 307620 307621 307622 307619 307648 307651 307659 307663 307656 307671 307672	flow cytometry; human; loading ...; fig s1c	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s1c). BMC Cancer (2020) ncbi
mouse monoclonal (L243) 307667 307666 307665 307661 307669 307668 307602 307626 307625 307620 307621 307622 307619 307641 307648 307651 307659 307663 307642 307656 307671 307672	flow cytometry; human; 3:50; loading ...; fig 1c	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples at 3:50 (fig 1c). Science (2020) ncbi
mouse monoclonal (L243) 307642	flow cytometry; human; 1:100; loading ...; fig s20c	BioLegend PATR-DQB1 antibody (Biolegend, 307642) was used in flow cytometry on human samples at 1:100 (fig s20c). Nat Commun (2020) ncbi
mouse monoclonal (L243) 307667 307666 307665 307661 307669 307668 307602 307626 307625 307620 307621 307622 307619 307648 307651 307659 307663 307656 307671 307672	mass cytometry; human; 0.5 mg/ml; loading ...; fig s11a	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in mass cytometry on human samples at 0.5 mg/ml (fig s11a). Nature (2020) ncbi
mouse monoclonal (L243) 307640	flow cytometry; human; loading ...; fig s20	BioLegend PATR-DQB1 antibody (Biolegend, 307640) was used in flow cytometry on human samples (fig s20). Science (2019) ncbi
mouse monoclonal (L243) 307640 307668 307602 307626 307625 307620 307621 307622 307619 307648 307651 307659 307663 307656 307671 307672	flow cytometry; human; loading ...; fig 6b	BioLegend PATR-DQB1 antibody (Biolegend, 307640) was used in flow cytometry on human samples (fig 6b). Cell Rep (2019) ncbi
mouse monoclonal (L243) 307629	flow cytometry; human; loading ...; fig 7a	BioLegend PATR-DQB1 antibody (BioLegend, 307629) was used in flow cytometry on human samples (fig 7a). J Exp Med (2020) ncbi
mouse monoclonal (L243) 307667 307666 307665 307661 307669 307668 307602 307626 307625 307620 307621 307622 307619 307641 307648 307651 307659 307663 307642 307656 307671 307672	flow cytometry; human; loading ...; fig s6c	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s6c). Science (2019) ncbi
mouse monoclonal (L243) 307619	flow cytometry; human; 1:50; loading ...; fig e4f	BioLegend PATR-DQB1 antibody (Biolegend, 307619) was used in flow cytometry on human samples at 1:50 (fig e4f). Nature (2019) ncbi
mouse monoclonal (L243) 307667 307666 307665 307661 307669 307668 307602 307626 307625 307620 307621 307622 307619 307648 307651 307659 307663 307656 307671 307672	flow cytometry; human; loading ...	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples . JCI Insight (2019) ncbi
mouse monoclonal (L243) 307642	flow cytometry; human; loading ...; fig 2d	BioLegend PATR-DQB1 antibody (Biolegend, 307642) was used in flow cytometry on human samples (fig 2d). Immunity (2019) ncbi
mouse monoclonal (L243) 307602	flow cytometry; human; loading ...; fig s2d	BioLegend PATR-DQB1 antibody (Biolegend, 307602) was used in flow cytometry on human samples (fig s2d). Cell (2019) ncbi
mouse monoclonal (L243) 307667 307666 307665 307661 307669 307668 307602 307626 307625 307620 307621 307622 307619 307628 307627 307648 307651 307659 307663 307656 307671 307672	flow cytometry; human; loading ...; fig 8a	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 8a). elife (2019) ncbi
mouse monoclonal (L243) 307626	flow cytometry; human; loading ...; fig 1b	BioLegend PATR-DQB1 antibody (Biolegend, 307626) was used in flow cytometry on human samples (fig 1b). Cell Mol Gastroenterol Hepatol (2020) ncbi
mouse monoclonal (L243) 307603	flow cytometry; human; loading ...; fig 6	BioLegend PATR-DQB1 antibody (BioLegend, 307603) was used in flow cytometry on human samples (fig 6). Gastroenterol Res Pract (2019) ncbi
mouse monoclonal (L243) 307659	other; human; loading ...; fig 4b	BioLegend PATR-DQB1 antibody (BioLegend, 307659) was used in other on human samples (fig 4b). Cell (2019) ncbi
mouse monoclonal (L243) 307667 307666 307665 307661 307669 307668 307602 307626 307625 307620 307621 307622 307619 307641 307648 307651 307659 307663 307642 307656 307671 307672	flow cytometry; human; loading ...; fig s1	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1). JCI Insight (2019) ncbi
mouse monoclonal (L243) 307667 307666 307665 307661 307669 307668 307602 307626 307625 307620 307621 307622 307619 307648 307651 307659 307663 307656 307671 307672	mass cytometry; human; loading ...; fig s1	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in mass cytometry on human samples (fig s1). J Exp Med (2019) ncbi
mouse monoclonal (L243) 307667 307666 307665 307661 307669 307668 307602 307626 307625 307620 307621 307622 307619 307648 307651 307659 307663 307656 307671 307672	flow cytometry; human; loading ...; fig s1b	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1b). J Clin Invest (2019) ncbi
mouse monoclonal (L243) 307667 307666 307665 307661 307669 307668 307602 307626 307625 307620 307621 307622 307619 307648 307651 307659 307663 307656 307671 307672	flow cytometry; human; loading ...; fig 1a	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1a). BMC Res Notes (2019) ncbi
mouse monoclonal (L243) 307602	mass cytometry; human; loading ...; fig 2b	BioLegend PATR-DQB1 antibody (Biolegend, 307602) was used in mass cytometry on human samples (fig 2b). Cell (2019) ncbi
mouse monoclonal (L243) 307650	flow cytometry; human; 1:100; loading ...; fig s1c, s3a	BioLegend PATR-DQB1 antibody (Biolegend, 307650) was used in flow cytometry on human samples at 1:100 (fig s1c, s3a). Cancer Cell (2019) ncbi
mouse monoclonal (L243) 307623	flow cytometry; human; 2 ug/ml; loading ...; fig s13	BioLegend PATR-DQB1 antibody (BioLegend, 307623) was used in flow cytometry on human samples at 2 ug/ml (fig s13). Science (2019) ncbi
mouse monoclonal (L243) 307624	flow cytometry; human; loading ...; fig 3a	BioLegend PATR-DQB1 antibody (BioLegend, 307624) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2019) ncbi
mouse monoclonal (L243) 307610	flow cytometry; human; 1:1; fig 5a	BioLegend PATR-DQB1 antibody (BioLegend, 307610) was used in flow cytometry on human samples at 1:1 (fig 5a). Nat Commun (2019) ncbi
mouse monoclonal (L243) 307602 307626 307625 307620 307621 307622 307619 307648 307649 307651 307650 307656	flow cytometry; human; loading ...; fig 1a	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (L243) 307667 307666 307665 307661 307669 307668 307618 307617 307602 307626 307625 307620 307621 307622 307619 307648 307651 307659 307663 307656 307671 307672	flow cytometry; human; 1:200; loading ...; fig 1b	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples at 1:200 (fig 1b). Front Immunol (2018) ncbi
mouse monoclonal (L243) 307618	flow cytometry; human; loading ...; fig s3k	BioLegend PATR-DQB1 antibody (Biolegend, 307618) was used in flow cytometry on human samples (fig s3k). Cell Rep (2018) ncbi
mouse monoclonal (L243) 307667 307666 307665 307661 307669 307668 307602 307626 307625 307620 307621 307622 307619 307648 307651 307610 307609 307659 307663 307656 307671 307672 307658 307657	flow cytometry; mouse; loading ...; fig 3b	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on mouse samples (fig 3b). J Clin Invest (2019) ncbi
mouse monoclonal (L243) 307616	flow cytometry; human; loading ...; fig 1c	BioLegend PATR-DQB1 antibody (BioLegend, 307616) was used in flow cytometry on human samples (fig 1c). J Exp Med (2018) ncbi
mouse monoclonal (L243) 307602 307626 307625 307620 307621 307622 307619 307648 307651 307656	flow cytometry; human; loading ...; fig 4b	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 4b). J Immunol (2018) ncbi
mouse monoclonal (L243) 307602	flow cytometry; human; loading ...; fig 1a	BioLegend PATR-DQB1 antibody (Biolegend, 307602) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
mouse monoclonal (L243) 307624	flow cytometry; human; loading ...; fig s2d	BioLegend PATR-DQB1 antibody (BioLegend, 307624) was used in flow cytometry on human samples (fig s2d). Nat Immunol (2018) ncbi
mouse monoclonal (L243) 307629 307602 307626 307625 307620 307621 307622 307619 307648 307630 307651 307656	flow cytometry; human; loading ...; fig 1a	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi
mouse monoclonal (L243) 307602 307626 307625 307620 307621 307622 307619 307648 307651 307659 307656	flow cytometry; human; loading ...; fig s3b	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s3b). J Exp Med (2018) ncbi
mouse monoclonal (L243) 307616	flow cytometry; human; loading ...; fig 1a	BioLegend PATR-DQB1 antibody (Biolegend, 307616) was used in flow cytometry on human samples (fig 1a). J Clin Invest (2018) ncbi
mouse monoclonal (L243) 307616	flow cytometry; human; loading ...; fig 1a	BioLegend PATR-DQB1 antibody (Biolegend, 307616) was used in flow cytometry on human samples (fig 1a). Nucleic Acids Res (2018) ncbi
mouse monoclonal (L243) 307602	blocking or activating experiments; human; loading ...; fig s2b	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in blocking or activating experiments on human samples (fig s2b). Nat Med (2018) ncbi
mouse monoclonal (L243) 307667 307666 307665 307661 307669 307668 307602 307626 307625 307620 307621 307622 307619 307648 307651 307659 307663 307656 307671 307672	flow cytometry; human; loading ...; fig s1	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1). J Biol Chem (2018) ncbi
mouse monoclonal (L243) 307602	flow cytometry; human; loading ...; fig 4a	BioLegend PATR-DQB1 antibody (BioLegend, H243) was used in flow cytometry on human samples (fig 4a). Int J Infect Dis (2018) ncbi
mouse monoclonal (L243) 307602 307626 307625 307620 307621 307622 307619 307648 307651 307659 307656	flow cytometry; human; loading ...; fig 1b	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 1b). JCI Insight (2018) ncbi
mouse monoclonal (L243) 307602 307626 307625 307624 307623 307620 307621 307622 307619 307633 307648 307651 307656	flow cytometry; human; loading ...; fig 3b	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 3b). Oncol Lett (2018) ncbi
mouse monoclonal (L243) 307602 307626 307625 307620 307621 307622 307619 307648 307651 307656	flow cytometry; human; fig 1a	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1a). J Exp Med (2018) ncbi
mouse monoclonal (L243) 307602	mass cytometry; human; loading ...; fig 2a	In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (L243) 307616	flow cytometry; human; 1:50; loading ...	In order to define the transcriptional network specifies conferring microglia identity, BioLegend PATR-DQB1 antibody (BioLegend, 307616) was used in flow cytometry on human samples at 1:50. Science (2017) ncbi
mouse monoclonal (L243) 307602	flow cytometry; human; loading ...; tbl s3	In order to conduct a phenotypical investigation of clear cell renal cell carcinoma, BioLegend PATR-DQB1 antibody (biolegend, L243) was used in flow cytometry on human samples (tbl s3). Cell (2017) ncbi
mouse monoclonal (L243) 307602	mass cytometry; human; loading ...; fig 1h flow cytometry; human	In order to map the lineage of human dendritic cells, BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in mass cytometry on human samples (fig 1h) and in flow cytometry on human samples . Science (2017) ncbi
mouse monoclonal (L243) 307602	flow cytometry; human; loading ...; fig s6a	In order to investigate the involvement of the TRIF pathway against the infection of Zika, Chikungunya, and Dengue viruses, BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s6a). MBio (2017) ncbi
mouse monoclonal (L243) 307602	flow cytometry; human; loading ...; fig st12	In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
mouse monoclonal (L243) 307602	flow cytometry; human; loading ...; fig 2e	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 2e). Oncoimmunology (2017) ncbi
mouse monoclonal (L243) 307603 307604 307602 307626 307625 307620 307621 307622 307619 307648 307651 307632 307656	flow cytometry; human; 1:200; loading ...; fig s1d	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples at 1:200 (fig s1d). Nat Commun (2017) ncbi
mouse monoclonal (L243) 307629 307602 307648 307630 307651	flow cytometry; human; loading ...; fig 2b	In order to analyze B-cell responses to meningococcal polysaccharide and conjugate vaccines against Neisseria meningitidis, BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 2b). Genome Med (2017) ncbi
mouse monoclonal (L243) 307602 307648 307651	flow cytometry; mouse; loading ...; fig 2d	In order to study the impact of modulating IFN-I signaling during suppressive combined antiretroviral therapy, BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on mouse samples (fig 2d). J Clin Invest (2017) ncbi
mouse monoclonal (L243) 307602 307628 307627 307648 307651	flow cytometry; rhesus macaque; loading ...; fig 7a	In order to study the efficacy of nanoparticle adjuvants for inducing protective immunity against simian immunodeficiency virus, BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on rhesus macaque samples (fig 7a). J Virol (2017) ncbi
mouse monoclonal (L243) 307602 307648 307651	flow cytometry; human; loading ...; tbl 1	In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (L243) 307602	flow cytometry; human; loading ...; fig 3b	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 3b). Oncotarget (2016) ncbi
mouse monoclonal (L243) 307602 307648 307651	flow cytometry; human; loading ...	In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
mouse monoclonal (L243) 307606	flow cytometry; human; loading ...; fig 2a	BioLegend PATR-DQB1 antibody (BioLegend, 307606) was used in flow cytometry on human samples (fig 2a). Oncogene (2017) ncbi
mouse monoclonal (L243) 307602	flow cytometry; mouse; loading ...; fig 1c	In order to test if Mincle signaling drives intrahepatic inflammation and liver injury in Con A hepatitis, BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2016) ncbi
mouse monoclonal (L243) 307624	flow cytometry; human; loading ...; tbl 2	In order to identify peanut proteins that can predict peanut allergy., BioLegend PATR-DQB1 antibody (Biolegend, 307624) was used in flow cytometry on human samples (tbl 2). J Allergy Clin Immunol (2017) ncbi
mouse monoclonal (L243) 307628	flow cytometry; human; loading ...; fig 2b	In order to elucidate the mechanisms by which DRibbles induce T-cell activation, BioLegend PATR-DQB1 antibody (Biolegend, 307628) was used in flow cytometry on human samples (fig 2b). Cell Death Dis (2016) ncbi
mouse monoclonal (L243) 307602 307648 307651	flow cytometry; human; loading ...	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples . J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (L243) 307602	flow cytometry; human; loading ...; fig 1b	In order to ask if CD2 is involved in the response of adaptive natural killer cells to HCMV, BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1b). Eur J Immunol (2016) ncbi
mouse monoclonal (L243) 307602	flow cytometry; human; fig 6a	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 6a). J Biol Chem (2016) ncbi
mouse monoclonal (L243) 307603 307604 307602 307626 307625 307620 307621 307622 307619 307648 307651 307632 307656	flow cytometry; human; loading ...; fig 2b	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 2b). PLoS ONE (2016) ncbi
mouse monoclonal (L243) 307603 307604 307602 307626 307625 307620 307621 307622 307619 307648 307651 307632 307656	flow cytometry; human; loading ...; fig 7a	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 7a). J Biol Chem (2016) ncbi
mouse monoclonal (L243) 307602	flow cytometry; human; loading ...; fig s3	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s3). Nature (2016) ncbi
mouse monoclonal (L243) 307602 307648 307651 307610 307609 307658 307657	flow cytometry; human; loading ...; fig 3	In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 3). Am J Transplant (2016) ncbi
mouse monoclonal (L243) 307602	flow cytometry; human; fig s1c immunocytochemistry; human	In order to discuss the impact of filaggrin mutations on the development of atopic dermatitis, BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1c) and in immunocytochemistry on human samples . J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (L243) 307616	flow cytometry; human; 1:200; loading ...; fig s1a	In order to find that central nervous system infiltration of peripheral monocytes correlates with improved motor neuron survival in a genetic amyotrophic lateral sclerosis mouse model, BioLegend PATR-DQB1 antibody (Biolegend, 307616) was used in flow cytometry on human samples at 1:200 (fig s1a). Acta Neuropathol (2016) ncbi
mouse monoclonal (L243) 307602 307648 307651 307644 307643	flow cytometry; human; fig s6a	In order to test if AML patients treated decitabine have induced expression of cancer testis antigens, BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s6a). Oncotarget (2016) ncbi
mouse monoclonal (L243) 307616 307615 307602 307648 307651	flow cytometry; human; 1:20; fig 2	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples at 1:20 (fig 2). Nat Commun (2016) ncbi
mouse monoclonal (L243) 307629 307602 307648 307630 307651	other; human; loading ...; fig st1 flow cytometry; human; loading ...; fig st3	In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in other on human samples (fig st1) and in flow cytometry on human samples (fig st3). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (L243) 307610	flow cytometry; human; loading ...; fig 1a	In order to study the role of human head and neck squamous cell carcinoma-associated semaphorin 4d in myeloid-derived suppressor cells, BioLegend PATR-DQB1 antibody (BioLegend, 307610) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (L243) 307602 307648 307651	flow cytometry; human; loading ...; fig s1b	In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s1b). J Immunol (2015) ncbi
mouse monoclonal (L243) 307628	flow cytometry; human; fig 1	BioLegend PATR-DQB1 antibody (Biolegend, 307628) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (L243) 307602 307648 307651	flow cytometry; human	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples . Clin Cancer Res (2016) ncbi
mouse monoclonal (L243) 307604	flow cytometry; human	In order to identify the cell surface markers in synovial mesenchymal stem cells, BioLegend PATR-DQB1 antibody (Biolegend, 307604) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (L243) 307602	flow cytometry; human; fig 2a	In order to investigate the effect of thymosin on HL-60 cell maturation, BioLegend PATR-DQB1 antibody (Biolegend, 307602) was used in flow cytometry on human samples (fig 2a). Mol Med Rep (2015) ncbi
mouse monoclonal (L243) 307602	flow cytometry; human; loading ...; tbl 1	In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (L243) 307602 307648 307651	flow cytometry; human; fig 3	In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 3). Mucosal Immunol (2016) ncbi
mouse monoclonal (L243) 307629 307602 307648 307630 307651	flow cytometry; human; tbl s1	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (tbl s1). PLoS ONE (2015) ncbi
mouse monoclonal (L243) 307617	flow cytometry; human; loading ...; fig 9a	In order to explore a macrophage TLR9-BTK-calcineurin-NFAT signaling pathway involved in impair fungal immunity, BioLegend PATR-DQB1 antibody (Biolegend, 307617) was used in flow cytometry on human samples (fig 9a). EMBO Mol Med (2015) ncbi
mouse monoclonal (L243) 307602	blocking or activating experiments; human; 15 ug/ml; fig 4	BioLegend PATR-DQB1 antibody (BioLegend, L432) was used in blocking or activating experiments on human samples at 15 ug/ml (fig 4). Vaccine (2015) ncbi
mouse monoclonal (L243) 307618 307617 307602 307648 307651	flow cytometry; human	In order to discuss how inflammation contributes to pulmonary arterial hypertension, BioLegend PATR-DQB1 antibody (BioLegend, clone L243) was used in flow cytometry on human samples . Chest (2015) ncbi
mouse monoclonal (L243) 307602 307648 307651 307644 307643	flow cytometry; human; loading ...; fig 5	In order to study the immune effects of tadalafil in patients with head and neck squamous cell carcinoma., BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 5). Clin Cancer Res (2015) ncbi
mouse monoclonal (L243) 307603 307604 307602 307648 307651 307632	flow cytometry; human; fig 3	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 3). Nephrol Dial Transplant (2015) ncbi
mouse monoclonal (L243) 307648 307651	flow cytometry; human	In order to identify the role of GammaDelta T cells in acute HIV infection, BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (L243) 307603 307604 307632	flow cytometry; human	BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (L243) 307604	flow cytometry; human; fig 1	In order to study the role of plasmacytoid dendritic cells in human immunodeficiency virus type 1 infection and pathogenesis, BioLegend PATR-DQB1 antibody (Biolegend, 307604) was used in flow cytometry on human samples (fig 1). PLoS Pathog (2014) ncbi
mouse monoclonal (L243) 307618 307617	flow cytometry; human	In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (L243) 307614	flow cytometry; human	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
mouse monoclonal (L243) 307602	flow cytometry; human; loading ...; fig 6b	BioLegend PATR-DQB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 6b). J Immunol (2014) ncbi
mouse monoclonal (L243) 307626 307625		In order to investigate the progression of innate responses to mycobacteria in infants, BioLegend PATR-DQB1 antibody (Biolegend, L243) was used . J Immunol (2014) ncbi
mouse monoclonal (L243) 307602 307648 307651	blocking or activating experiments; human; loading ...; fig 5A	In order to investigate human T lymphotropic virus type 1 bZIP factor-specific CD4 T cell responses, BioLegend PATR-DQB1 antibody (BioLegend, L243) was used in blocking or activating experiments on human samples (fig 5A). J Immunol (2014) ncbi

Articles Reviewed

Moreira T, Mangani D, Cox L, Leibowitz J, Lobo E, Oliveira M, et al. PD-L1+ and XCR1+ dendritic cells are region-specific regulators of gut homeostasis. Nat Commun. 2021;12:4907 pubmed publisher
Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed publisher
Gregorova M, Morse D, Brignoli T, Steventon J, Hamilton F, Albur M, et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. elife. 2020;9: pubmed publisher
Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed publisher
Stary V, Wolf B, Unterleuthner D, List J, Talic M, Laengle J, et al. Short-course radiotherapy promotes pro-inflammatory macrophages via extracellular vesicles in human rectal cancer. J Immunother Cancer. 2020;8: pubmed publisher
Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
Morrissey M, Byrne R, Nulty C, McCabe N, Lynam Lennon N, Butler C, et al. The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation. BMC Cancer. 2020;20:566 pubmed publisher
Park J, Botting R, Domínguez Conde C, Popescu D, Lavaert M, Kunz D, et al. A cell atlas of human thymic development defines T cell repertoire formation. Science. 2020;367: pubmed publisher
Mosaheb M, Dobrikova E, Brown M, Yang Y, Cable J, Okada H, et al. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. Nat Commun. 2020;11:524 pubmed publisher
Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed publisher
Uhlen M, Karlsson M, Zhong W, Tebani A, Pou C, Mikes J, et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366: pubmed publisher
Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
Yan D, Wang J, Sun H, Zamani A, Zhang H, Chen W, et al. TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis. J Exp Med. 2020;217: pubmed publisher
Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed publisher
Ramachandran P, Dobie R, Wilson Kanamori J, Dora E, Henderson B, Luu N, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575:512-518 pubmed publisher
Merola J, Reschke M, Pierce R, Qin L, Spindler S, Baltazar T, et al. Progenitor-derived human endothelial cells evade alloimmunity by CRISPR/Cas9-mediated complete ablation of MHC expression. JCI Insight. 2019;4: pubmed publisher
Dutertre C, Becht E, Irac S, Khalilnezhad A, Narang V, Khalilnezhad S, et al. Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells. Immunity. 2019;51:573-589.e8 pubmed publisher
Martin J, Chang C, Boschetti G, Ungaro R, Giri M, Grout J, et al. Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019;178:1493-1508.e20 pubmed publisher
Saliba D, Céspedes Donoso P, Balint S, Compeer E, Korobchevskaya K, Valvo S, et al. Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD40 ligand from helper T cells. elife. 2019;8: pubmed publisher
Di Blasi D, Boldanova T, Mori L, Terracciano L, Heim M, De Libero G. Unique T-Cell Populations Define Immune-Inflamed Hepatocellular Carcinoma. Cell Mol Gastroenterol Hepatol. 2020;9:195-218 pubmed publisher
Xia Y, Gao Y, Wang B, Zhang H, Zhang Q. Optimizing the Method of Cell Separation from Bile of Patients with Cholangiocarcinoma for Flow Cytometry. Gastroenterol Res Pract. 2019;2019:5436961 pubmed publisher
Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
Swaims Kohlmeier A, Haddad L, Li Z, Brookmeyer K, Baker J, Widom C, et al. Chronic immune barrier dysregulation among women with a history of violence victimization. JCI Insight. 2019;4: pubmed publisher
Fernandez I, Baxter R, Garcia Perez J, Vendrame E, Ranganath T, Kong D, et al. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019;216:1255-1267 pubmed publisher
Zhang J, Supakorndej T, Krambs J, Rao M, Abou Ezzi G, Ye R, et al. Bone marrow dendritic cells regulate hematopoietic stem/progenitor cell trafficking. J Clin Invest. 2019;129:2920-2931 pubmed publisher
Terahara K, Iwabuchi R, Hosokawa M, Nishikawa Y, Takeyama H, Takahashi Y, et al. A CCR5+ memory subset within HIV-1-infected primary resting CD4+ T cells is permissive for replication-competent, latently infected viruses in vitro. BMC Res Notes. 2019;12:242 pubmed publisher
Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
Cassetta L, Fragkogianni S, Sims A, Swierczak A, Forrester L, Zhang H, et al. Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets. Cancer Cell. 2019;35:588-602.e10 pubmed publisher
Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed publisher
Crippa S, Rossella V, Aprile A, Silvestri L, Rivis S, Scaramuzza S, et al. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity. J Clin Invest. 2019;129:1566-1580 pubmed publisher
Jin Y, Roberts G, Ferrara T, Ben S, van Geel N, Wolkerstorfer A, et al. Early-onset autoimmune vitiligo associated with an enhancer variant haplotype that upregulates class II HLA expression. Nat Commun. 2019;10:391 pubmed publisher
Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603 pubmed publisher
Jones G, Bain C, Fenton T, Kelly A, Brown S, Ivens A, et al. Dynamics of Colon Monocyte and Macrophage Activation During Colitis. Front Immunol. 2018;9:2764 pubmed publisher
Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
Poncette L, Chen X, Lorenz F, Blankenstein T. Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression. J Clin Invest. 2019;129:324-335 pubmed publisher
Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
Otsuka Y, Watanabe E, Shinya E, Okura S, Saeki H, Geijtenbeek T, et al. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. J Immunol. 2018;201:3006-3016 pubmed publisher
Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed publisher
Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed publisher
Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed publisher
Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed publisher
Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed publisher
Dumbovic G, Biayna J, Banús J, Samuelsson J, Roth A, Diederichs S, et al. A novel long non-coding RNA from NBL2 pericentromeric macrosatellite forms a perinucleolar aggregate structure in colon cancer. Nucleic Acids Res. 2018;46:5504-5524 pubmed publisher
Zacharakis N, Chinnasamy H, Black M, Xu H, Lu Y, Zheng Z, et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 2018;24:724-730 pubmed publisher
Melo Gonzalez F, Fenton T, Forss C, Smedley C, Goenka A, MacDonald A, et al. Intestinal mucin activates human dendritic cells and IL-8 production in a glycan-specific manner. J Biol Chem. 2018;293:8543-8553 pubmed publisher
Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed publisher
Liu R, Merola J, Manes T, Qin L, Tietjen G, Lopez Giraldez F, et al. Interferon-γ converts human microvascular pericytes into negative regulators of alloimmunity through induction of indoleamine 2,3-dioxygenase 1. JCI Insight. 2018;3: pubmed publisher
Fujisaka Y, Iwata T, Tamai K, Nakamura M, Mochizuki M, Shibuya R, et al. Long non-coding RNA HOTAIR up-regulates chemokine (C-C motif) ligand 2 and promotes proliferation of macrophages and myeloid-derived suppressor cells in hepatocellular carcinoma cell lines. Oncol Lett. 2018;15:509-514 pubmed publisher
Bujko A, Atlasy N, Landsverk O, Richter L, Yaqub S, Horneland R, et al. Transcriptional and functional profiling defines human small intestinal macrophage subsets. J Exp Med. 2018;215:441-458 pubmed publisher
Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
Gosselin D, Skola D, Coufal N, Holtman I, Schlachetzki J, Sajti E, et al. An environment-dependent transcriptional network specifies human microglia identity. Science. 2017;356: pubmed publisher
Chevrier S, Levine J, Zanotelli V, Silina K, Schulz D, Bacac M, et al. An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell. 2017;169:736-749.e18 pubmed publisher
See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
Pryke K, Abraham J, Sali T, Gall B, Archer I, Liu A, et al. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. MBio. 2017;8: pubmed publisher
Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed publisher
Zhang J, Xu X, Shi M, Chen Y, Yu D, Zhao C, et al. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. Oncoimmunology. 2017;6:e1258504 pubmed publisher
Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, et al. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nat Commun. 2017;8:14253 pubmed publisher
O CONNOR D, Clutterbuck E, Thompson A, Snape M, Ramasamy M, Kelly D, et al. High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine. Genome Med. 2017;9:11 pubmed publisher
Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed publisher
Kasturi S, Kozlowski P, Nakaya H, Burger M, Russo P, Pham M, et al. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques. J Virol. 2017;91: pubmed publisher
Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
Misra S, Selvam A, Wallenberg M, Ambati A, Matolcsy A, Magalhaes I, et al. Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells. Oncotarget. 2016;7:74686-74700 pubmed publisher
Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
Deng Y, Cheng J, Fu B, Liu W, Chen G, Zhang Q, et al. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Oncogene. 2017;36:1090-1101 pubmed publisher
Greco S, Torres Hernandez A, Kalabin A, Whiteman C, Rokosh R, Ravirala S, et al. Mincle Signaling Promotes Con A Hepatitis. J Immunol. 2016;197:2816-27 pubmed publisher
van Erp F, Knol E, Pontoppidan B, Meijer Y, van der Ent C, Knulst A. The IgE and basophil responses to Ara h 2 and Ara h 6 are good predictors of peanut allergy in children. J Allergy Clin Immunol. 2017;139:358-360.e8 pubmed publisher
Xing Y, Cao R, Hu H. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles). Cell Death Dis. 2016;7:e2322 pubmed publisher
Cerny D, Thi Le D, The T, Zuest R, Kg S, Velumani S, et al. Complete human CD1a deficiency on Langerhans cells due to a rare point mutation in the coding sequence. J Allergy Clin Immunol. 2016;138:1709-1712.e11 pubmed publisher
Rölle A, Halenius A, Ewen E, Cerwenka A, Hengel H, Momburg F. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur J Immunol. 2016;46:2420-2425 pubmed publisher
Wittmann A, Lamprinaki D, Bowles K, Katzenellenbogen E, Knirel Y, Whitfield C, et al. Dectin-2 Recognizes Mannosylated O-antigens of Human Opportunistic Pathogens and Augments Lipopolysaccharide Activation of Myeloid Cells. J Biol Chem. 2016;291:17629-38 pubmed publisher
Gadd V, Patel P, Jose S, Horsfall L, Powell E, Irvine K. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE. 2016;11:e0157771 pubmed publisher
Zanetti S, Ziblat A, Torres N, Zwirner N, Bouzat C. Expression and Functional Role of ?7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells. J Biol Chem. 2016;291:16541-52 pubmed publisher
Ruibal P, Oestereich L, LÃ¼dtke A, Becker Ziaja B, Wozniak D, Kerber R, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature. 2016;533:100-4 pubmed publisher
Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
Leitch C, Natafji E, Yu C, Abdul Ghaffar S, Madarasingha N, Venables Z, et al. Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol. 2016;138:482-490.e7 pubmed publisher
Zondler L, Müller K, Khalaji S, Bliederhäuser C, Ruf W, Grozdanov V, et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132:391-411 pubmed publisher
Srivastava P, Paluch B, Matsuzaki J, James S, Collamat Lai G, Blagitko Dorfs N, et al. Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy. Oncotarget. 2016;7:12840-56 pubmed publisher
Johnson D, Estrada M, Salgado R, Sanchez V, Doxie D, Opalenik S, et al. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy. Nat Commun. 2016;7:10582 pubmed publisher
Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
Younis R, Han K, Webb T. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells. J Immunol. 2016;196:1419-29 pubmed publisher
Schulz A, MÃ¤lzer J, Domingo C, JÃ¼rchott K, GrÃ¼tzkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
McCausland M, Juchnowski S, Zidar D, Kuritzkes D, Andrade A, Sieg S, et al. Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy. PLoS ONE. 2015;10:e0139474 pubmed publisher
Rosario M, Liu B, Kong L, Collins L, Schneider S, Chen X, et al. The IL-15-Based ALT-803 Complex Enhances FcÎ³RIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas. Clin Cancer Res. 2016;22:596-608 pubmed publisher
Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed publisher
Li X, Liu X, Zhao Y, Zhong R, Song A, Sun L. Effect of thymosin Î±â‚ on the phenotypic and functional maturation of dendritic cells from children with acute lymphoblastic leukemia. Mol Med Rep. 2015;12:6093-7 pubmed publisher
Pojero F, Flores Montero J, Sanoja L, PÃ©rez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed publisher
Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed publisher
Herbst S, Shah A, Mazon Moya M, Marzola V, Jensen B, Reed A, et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. EMBO Mol Med. 2015;7:240-58 pubmed publisher
Tomimaru Y, Mishra S, Safran H, Charpentier K, Martin W, De Groot A, et al. Aspartate-Î²-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma. Vaccine. 2015;33:1256-66 pubmed publisher
Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
Weed D, Vella J, Reis I, De La Fuente A, Gomez C, Sargi Z, et al. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res. 2015;21:39-48 pubmed publisher
Rogacev K, Zawada A, Hundsdorfer J, Achenbach M, Held G, Fliser D, et al. Immunosuppression and monocyte subsets. Nephrol Dial Transplant. 2015;30:143-53 pubmed publisher
Li Z, Li W, Li N, Jiao Y, Chen D, Cui L, et al. Î³Î´ T cells are involved in acute HIV infection and associated with AIDS progression. PLoS ONE. 2014;9:e106064 pubmed publisher
Chao Y, Kaliaperumal N, Chretien A, Tang S, Lee B, Poidinger M, et al. Human plasmacytoid dendritic cells regulate IFN-Î± production through activation-induced splicing of IL-18RÎ±. J Leukoc Biol. 2014;96:1037-46 pubmed publisher
Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 2014;10:e1004291 pubmed publisher
Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
Klinker M, Lizzio V, Reed T, Fox D, Lundy S. Human B Cell-Derived Lymphoblastoid Cell Lines Constitutively Produce Fas Ligand and Secrete MHCII(+)FasL(+) Killer Exosomes. Front Immunol. 2014;5:144 pubmed publisher
Fredriksson K, Mishra A, Lam J, Mushaben E, Cuento R, Meyer K, et al. The very low density lipoprotein receptor attenuates house dust mite-induced airway inflammation by suppressing dendritic cell-mediated adaptive immune responses. J Immunol. 2014;192:4497-509 pubmed publisher
Shey M, Nemes E, Whatney W, de Kock M, Africa H, Barnard C, et al. Maturation of innate responses to mycobacteria over the first nine months of life. J Immunol. 2014;192:4833-43 pubmed publisher
Narita T, Ishida T, Masaki A, Suzuki S, Ito A, Mori F, et al. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation. J Immunol. 2014;192:940-7 pubmed publisher

contribute

If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.

questions and comments